PROTALIX BIOTHERAPEUTICS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.18 USD | -1.67% |
|
+1.72% | -33.71% |
| 10/05 | Transcript : Protalix BioTherapeutics, Inc., Q1 2024 Earnings Call, May 10, 2024 | |
| 10/05 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Other Biotechnology & Medical Research | -1.67% | +1.72% | -33.71% | -44.34% | -71.22% | 87.98M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- PLX Stock
- Charts Protalix BioTherapeutics, Inc.
- Comparison Chart
